Relationships of varicella zoster virus (VZV)‐specific cell‐mediated immunity and persistence of VZV DNA in saliva and the development of postherpetic neuralgia in patients with herpes zoster. Issue 11 (23rd July 2019)
- Record Type:
- Journal Article
- Title:
- Relationships of varicella zoster virus (VZV)‐specific cell‐mediated immunity and persistence of VZV DNA in saliva and the development of postherpetic neuralgia in patients with herpes zoster. Issue 11 (23rd July 2019)
- Main Title:
- Relationships of varicella zoster virus (VZV)‐specific cell‐mediated immunity and persistence of VZV DNA in saliva and the development of postherpetic neuralgia in patients with herpes zoster
- Authors:
- Park, Seong Yeon
Kim, Ji Yeun
Kwon, Ji‐Soo
Jeon, Na Young
Kim, Min‐Chul
Chong, Yong Pil
Lee, Sang‐Oh
Choi, Sang‐Ho
Kim, Yang Soo
Woo, Jun Hee
Kim, Sung‐Han - Abstract:
- Abstract: There are no surrogate markers for the development of postherpetic neuralgia (PHN) in patients with herpes zoster (HZ). All patients with HZ were prospectively enrolled to evaluate the associations of saliva varicella zoster virus (VZV) DNA persistence and VZV‐specific cell‐mediated immunity (CMI) with the development of PHN. Slow clearers were defined if salivary VZV DNA persisted after day 15. Salivary VZV was detected in 60 (85.7%) of a total of 70 patients with HZ on initial presentation. Of 38 patients for whom follow‐up saliva samples were available, 26 (68.4%) were classified as rapid clearers and 12 (31.6%) as slow cleares. Initial VZV‐specific CMI was lower in slow clearers than rapid clearers (median 45 vs 158 spot forming cells/10 6 cells, P = .02). Of the 70 patients with HZ, 22 (31.4%) eventually developed PHN. Multivariate analysis showed that slow clearers (OR, 15.7, P = .01) and lower initial VZV‐specific CMI (OR, 13.8, P = .04) were independent predictors of the development of PHN, after adjustment for age and immunocompromised status. Initial low VZV CMI response and persistence of VZV DNA in saliva may be associated with the development of PHN. HIGHLIGHTS: Herpes zoster patients with persistent salivary varicella zoster virus (VZV) DNA and lower VZV‐specific initial cell mediated immune (CMI) responses experienced more post‐herpetic neuralgia (PHN) than the comparator. These findings suggest that low VZV‐specific CMI results in prolonged viralAbstract: There are no surrogate markers for the development of postherpetic neuralgia (PHN) in patients with herpes zoster (HZ). All patients with HZ were prospectively enrolled to evaluate the associations of saliva varicella zoster virus (VZV) DNA persistence and VZV‐specific cell‐mediated immunity (CMI) with the development of PHN. Slow clearers were defined if salivary VZV DNA persisted after day 15. Salivary VZV was detected in 60 (85.7%) of a total of 70 patients with HZ on initial presentation. Of 38 patients for whom follow‐up saliva samples were available, 26 (68.4%) were classified as rapid clearers and 12 (31.6%) as slow cleares. Initial VZV‐specific CMI was lower in slow clearers than rapid clearers (median 45 vs 158 spot forming cells/10 6 cells, P = .02). Of the 70 patients with HZ, 22 (31.4%) eventually developed PHN. Multivariate analysis showed that slow clearers (OR, 15.7, P = .01) and lower initial VZV‐specific CMI (OR, 13.8, P = .04) were independent predictors of the development of PHN, after adjustment for age and immunocompromised status. Initial low VZV CMI response and persistence of VZV DNA in saliva may be associated with the development of PHN. HIGHLIGHTS: Herpes zoster patients with persistent salivary varicella zoster virus (VZV) DNA and lower VZV‐specific initial cell mediated immune (CMI) responses experienced more post‐herpetic neuralgia (PHN) than the comparator. These findings suggest that low VZV‐specific CMI results in prolonged viral replication accompanied by neural damage and PHN. … (more)
- Is Part Of:
- Journal of medical virology. Volume 91:Issue 11(2019)
- Journal:
- Journal of medical virology
- Issue:
- Volume 91:Issue 11(2019)
- Issue Display:
- Volume 91, Issue 11 (2019)
- Year:
- 2019
- Volume:
- 91
- Issue:
- 11
- Issue Sort Value:
- 2019-0091-0011-0000
- Page Start:
- 1995
- Page End:
- 2000
- Publication Date:
- 2019-07-23
- Subjects:
- cell mediated immunity -- herpes zoster -- postherpetic neuralgia -- saliva -- varicella‐zoster virus (VZV)
Virology -- Periodicals
616 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1096-9071 ↗
http://www.interscience.wiley.com/jpages/0146-6615 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/jmv.25543 ↗
- Languages:
- English
- ISSNs:
- 0146-6615
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5017.095000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 11687.xml